ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.9116 — Morgan Stanley/VTG)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 342/04)

1. On 13 September 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Warwick Holding GmbH (‘Warwick Holding’, Germany), controlled by Morgan Stanley (United States of America), — VTG Aktiengesellschaft (‘VTG’, Germany). Warwick Holding acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of VTG. The concentration is accomplished by way of public bid announced on 16 July 2018.

2. The business activities of the undertakings concerned are: — for Warwick Holding: indirectly, wholly owned subsidiary of funds advised by Morgan Stanley Infrastructure. Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services, — for VTG: provider of wagon hire and rail logistics services with a fleet of some 83 000 rail freight wagons, as well as of multimodal logistics services, focusing on rail transport and global tank container transport.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9116 — Morgan Stanley/VTG Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
3.

The Advisory Committee (10 Member States) agrees with the Commission’s definitions of the relevant product markets as stated in the draft decision for the purpose of assessing the present operation, in particular: a. the wholesale supply of ophthalmic substrate; b. the wholesale supply of finished ophthalmic lenses, leaving open the possibility of further segmentation by material, prescription design or distribution channel; c. the wholesale supply of frames, leaving open the possibility of further segmentation by price point, branding and distribution channel; d. the wholesale supply of sunglasses, leaving open the possibility of further segmentation by price point, branding and distribution channel; e. the supply of ophthalmic machines, leaving open the possibility of further segmentation between surfacing, coating, industrial glazing and commercial glazing (‘table-top edgers’); f. the supply of consumables, with the precise definition left open; g. the optical retail market, leaving open the possibility of further segmentation between bricks-and-mortar and online sales; and h. the supply of contact lenses, leaving open the possibility of further segmentation between soft and hard lenses.
Non-opposition to a notified concentration

(Case M.9098 — Goldman Sachs/Orix/ILS)

(Text with EEA relevance)

(2018/C 347/02)

On 20 September 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9098. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9079 — Advent International Corporation/KN Group)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 345/09)

1. On 20 September 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Advent International Corporation (‘AIC’, United States), — KN Network Services Holdings Limited (‘KN’, Ireland). AIC acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of KN. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for AIC: private equity investor which sponsors funds that invest globally, — for KN: provision of services to the telecommunication, media installations, transport infrastructure and power sectors, in Ireland and in the United Kingdom.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9079 — Advent International Corporation/KN Group Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9117 — Saudi Aramco/Arlanxeo)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 365/06)

1. On 2 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Aramco Overseas Holdings Coöperatief U.A. (the Netherlands) (‘AOHC’), a wholly owned subsidiary of Saudi Arabian Oil Company (the Kingdom of Saudi Arabia) (‘Saudi Aramco’), and — Arlanxeo Holding B.V. (the Netherlands) (‘Arlanxeo’). Saudi Aramco, through its wholly owned subsidiary AOHC, acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Arlanxeo. Arlanxeo is currently jointly controlled by Saudi Aramco and Lanxess Deutschland GmbH. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Saudi Aramco is engaged in the exploration, production and marketing of crude oil and in the product and marketing of refined products. — Arlanxeo is a specialty chemicals company that produces and offers a broad range of synthetic rubbers products.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9117 — Saudi Aramco/Arlanxeo Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9099 — Jin Jiang/Radisson)

(Text with EEA relevance)

(2018/C 359/06)

1. On 28 September 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Jin Jiang International Holdings Co., Ltd (‘Jin Jiang’, China), a State-owned company, — Radisson Holdings, Inc. (United States of America) and Radisson Hospitality AB (Sweden) (together ‘Radisson’). Jin Jiang acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Radisson. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Jin Jiang: a hospitality and travel group that develops and manages hotels in China and the rest of the world. Jin Jiang operates a wide range of hotels, under the brands J.Hotel, Jin Jiang, Metropolo, Jin Jiang Inn, the series of brands under Groupe du Louvre, the series of brands under Plateno Group and the series of brands under Vienna Hotel, — for Radisson: an operator of a range of hotel brands with a focus on the luxury, upper upscale, upscale and upper midscale segments. In the EEA, these brands include Radisson Collection, Radisson Blu, Radisson, Radisson Red, Park Plaza, Park Inn by Radisson.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9099 — Jin Jiang/Radisson Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.8770 — Prysmian/General Cable)

(Text with EEA relevance)

(2018/C 376/03)

On 8 May 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8770. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.8995 — Magna/Olsa)

(Text with EEA relevance)

(2018/C 368/01)

On 28 September 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8995. EUR-Lex is the on-line access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9132 — ICF Novedis/CDC Habitat/Swiss Life REIM/Foncière Vesta)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 388/11)

1. On 18 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — ICF Novedis SA (‘ICF Novedis’, France), belonging to the SNCF group (France), — CDC Habitat SAEM (‘CDC Habitat’, France), belonging to the Caisse des Dépôts et Consignations group (France), — Swiss Life REIM (France) SA (‘Swiss Life REIM’, France), belonging to the Swiss Life group (Switzerland). ICF Novedis, CDC Habitat and Swiss Life REIM acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Foncière Vesta, a company that owns a property portfolio that was until now controlled solely by the SNCF group. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — ICF Novedis: housing subsidiary of the SNCF group, an undertaking operating in the transport of passengers and goods, — CDC Habitat: public-interest property subsidiary of the Caisse des Dépôts et Consignations active in the social housing and affordable housing sectors, — Swiss Life REIM: asset management company wholly owned and controlled by the Swiss Life group operating in the insurance and asset management sector.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission no later than 10 days following the date on which this notification is published. The following reference should always be specified: M.9132 — ICF Novedis/CDC Habitat/Swiss Life REIM/Foncière Vesta Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.8832 — Knauf/Armstrong)

(Text with EEA relevance)

(2018/C 384/07)

1.

On 17 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 )

This notification concerns the following undertakings:

— Knauf International GmbH (Germany),

— Armstrong World Industries, Inc. (United States).

Knauf International GmbH (‘Knauf’) will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control over (i) subsidiaries of Armstrong World Industries, Inc. (‘Armstrong’) in Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), and (ii) designated subsidiaries of Armstrong’s joint venture with Worthington Industries with operations in EMEA and APAC (jointly ‘the Target’).

The concentration is accomplished by way of purchase of shares.

The concentration has been referred to the Commission by the Austrian Federal Competition Authority, pursuant to Article 22(3) of the Merger Regulation. The referral was subsequently joined by Germany, Lithuania, Spain and the United Kingdom.

The same concentration was already notified to the Commission on 20 June 2018, but the notification was subsequently withdrawn on 24 July 2018
Official Journal of the European Union

Prior notification of a concentration

(Case M.9160 — Centerbridge/Hospital Topco)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 401/10)

1. On 29 October 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Centerbridge Partners, L.P. (‘Centerbridge’, United States of America), — Hospital Topco Limited (‘Hospital Topco’, United Kingdom). Centerbridge acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Hospital Topco. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Centerbridge: investment management firm focused on private equity and distressed investment opportunities, — for Hospital Topco: parent company of the healthcare group that carries out its operations under the BMI Healthcare brand, and the property interest holding companies.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9160 — Centerbridge/Hospital Topco Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9119 — SEGRO/PSPIB/Warehouse)

(Text with EEA relevance)

(2018/C 398/08)

On 25 October 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9119. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9054 — Broadcom/CA)

(Text with EEA relevance)

(2018/C 412/01)

On 12 October 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9054. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.8829 — Total Produce/Dole Food Company)

(Text with EEA relevance)

(2018/C 407/01)

On 30 July 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8829. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.